SynthesisFrontiers in oncology2021

Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Tiange Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.